Even if anti-apoptotic Bcl-2 proteins have been studied in the context of CRC, the available data are inconsistent and no comprehensive study investigating the therapeutic potential of Bcl-xL is available. This evidence concerns the gene BCL2L1 and colorectal carcinoma.